Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Studying How Viruses Trigger Flare-Ups in Chronic Lung Disease

Follows adults with chronic lung disease, sampling them when well and during flare-ups.

Plain-language title generated from the registry record
Registry title: Exploring How Viral Infections Affect People With Chronic Lung Disease

Key facts

Where
London, United KingdomSee the site

Where in United Kingdom

  • Royal Brompton HospitalLondon, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Imperial College London
Trial code
NCT06625944
Record updated
14 July 2025
Original description
Many people with chronic lung disease have disease flare-ups. It was previously believed that these were mainly caused by bacteria but recent evidence suggests that viruses could be an important trigger. This study will recruit volunteers with chronic lung disease and take samples both when well (at baseline) and during flare-ups (exacerbations) to better understand the role of viruses in triggering exacerbations and also how the immune response is affected. The researchers will follow the volunteers\' progress for up to two years. Whenever they get unwell they will take some samples (nose swabs, finger prick testing, phlegm sample) and post them to the researchers. Then, they will come in for a visit for more samples (blood tests, further swabs) and a review.Read full original descriptionShow less

Prospective Cohort Study to Understand Impact of Viral Infection in Chronic Lung Disease

Many people with chronic lung disease have disease flare-ups. It was previously believed that these were mainly caused by bacteria but recent evidence suggests that viruses could be an important trigger. This study will recruit volunteers with chronic lung disease and take samples both when well (at baseline) and during flare-ups (exacerbations) to better understand the role of viruses in triggering exacerbations and also how the immune response is affected. The researchers will follow the volunteers\' progress for up to two years. Whenever they get unwell they will take some samples (nose swabs, finger prick testing, phlegm sample) and post them to the researchers. Then, they will come in for a visit for more samples (blood tests, further swabs) and a review.

Inclusion: Adults with a physician confirmed diagnosis of chronic airway disease (e.g. COPD and bronchiectasis) according to established diagnostic criteria; AND; Prior history of exacerbation within last year (defined as requiring antibiotic and/or corticosteroids).

Exclusion: Inability to complete daily symptom diaries and/or attend for clinical assessments; Exacerbation within 4 weeks of study recruitment and/or clinical instability at the time of recruitment; Pregnancy.

ClinicalTrials.gov NCT06625944